Literature DB >> 1731532

Expression of monocyte chemotactic protein-1 in human melanoma in vivo.

D T Graves1, R Barnhill, T Galanopoulos, H N Antoniades.   

Abstract

A common feature of human melanoma is infiltration by monocytes at early stages of tumorigenesis. This infiltration may be highly significant since macrophages have the capacity to alter the behavior of tumor cells. The authors previously demonstrated that the predominant monocyte chemoattractant produced by tumor cells in vitro was monocyte chemotactic protein-1 (MCP-1). The authors identify the expression of MCP-1 in pathologic specimens of both primary and metastatic human melanoma but not in normal skin. The finding that MCP-1 is produced by malignant melanoma suggests that specific genes are expressed in tumor cells that can induce the recruitment of monocytes in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731532      PMCID: PMC1886253     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

Review 1.  Phenotype and functions of intratumoral macrophages.

Authors:  W H McBride
Journal:  Biochim Biophys Acta       Date:  1986-08-05

Review 2.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

3.  Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin.

Authors:  V M Dixit; S Green; V Sarma; L B Holzman; F W Wolf; K O'Rourke; P A Ward; E V Prochownik; R M Marks
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

4.  Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.

Authors:  S D Cushing; J A Berliner; A J Valente; M C Territo; M Navab; F Parhami; R Gerrity; C J Schwartz; A M Fogelman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Regulation of the macrophage content of neoplasms by chemoattractants.

Authors:  B Bottazzi; N Polentarutti; R Acero; A Balsari; D Boraschi; P Ghezzi; M Salmona; A Mantovani
Journal:  Science       Date:  1983-04-08       Impact factor: 47.728

6.  Production of an anti-tumour cytotoxin by human monocytes.

Authors:  N Matthews
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

7.  Mechanism of macrophage-mediated cytotoxicity: production of a soluble cytotoxic factor.

Authors:  B E Drysdale; C M Zacharchuk; H S Shin
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

8.  A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.

Authors:  W H Clark; D E Elder; D Guerry; M N Epstein; M H Greene; M Van Horn
Journal:  Hum Pathol       Date:  1984-12       Impact factor: 3.466

9.  Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype.

Authors:  E B Bröcker; G Zwadlo; L Suter; M Brune; C Sorg
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

10.  Identification and quantification of subsets of mononuclear inflammatory cells in melanocytic and other human tumors.

Authors:  M S Nestor; A J Cochran
Journal:  Pigment Cell Res       Date:  1987
View more
  31 in total

1.  The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.

Authors:  M G Luciani; A Stoppacciaro; G Peri; A Mantovani; L P Ruco
Journal:  Mol Pathol       Date:  1998-10

2.  Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes.

Authors:  Yanping Ding; Nan Song; Yongzhang Luo
Journal:  Cancer Microenviron       Date:  2012-04-20

Review 3.  Tissue-specific homing of immune cells in malignant skin tumors.

Authors:  Hajnalka Jókai; Márta Marschalkó; Judit Csomor; József Szakonyi; Orsolya Kontár; Gábor Barna; Sarolta Kárpáti; Péter Holló
Journal:  Pathol Oncol Res       Date:  2012-04-24       Impact factor: 3.201

4.  Lactoferrin suppresses the Epstein-Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9.

Authors:  Ying Zheng; Zailong Qin; Qiurong Ye; Pan Chen; Zhen Wang; Qun Yan; Zhaohui Luo; Xiaoping Liu; Yanhong Zhou; Wei Xiong; Jian Ma; Guiyuan Li
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

5.  Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice.

Authors:  Jennifer L Owen; Michael F Criscitiello; Stephania Libreros; Ramon Garcia-Areas; Kathleen Guthrie; Marta Torroella-Kouri; Vijaya Iragavarapu-Charyulu
Journal:  Cell Immunol       Date:  2011-05-10       Impact factor: 4.868

6.  Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration.

Authors:  F Marra; R DeFranco; C Grappone; S Milani; S Pastacaldi; M Pinzani; R G Romanelli; G Laffi; P Gentilini
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

7.  Macrophages in skin melanoma-the key element in melanomagenesis.

Authors:  Malgorzata Pieniazek; Rafal Matkowski; Piotr Donizy
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

8.  Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment.

Authors:  Sharon Wei Ling Lee; R J Seager; Felix Litvak; Fabian Spill; Je Lin Sieow; Penny Hweixian Leong; Dillip Kumar; Alrina Shin Min Tan; Siew Cheng Wong; Giulia Adriani; Muhammad Hamid Zaman; And Roger D Kamm
Journal:  Integr Biol (Camb)       Date:  2020-04-20       Impact factor: 2.192

9.  Expression of monocyte chemoattractant protein 1 in human inflamed gingival tissues.

Authors:  X Yu; H N Antoniades; D T Graves
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

Review 10.  Chemokines and the microenvironment in neuroectodermal tumor-host interaction.

Authors:  Rajasekharan Somasundaram; Dorothee Herlyn
Journal:  Semin Cancer Biol       Date:  2008-11-13       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.